Imatinib Mesylate Tablets market size is estimated to be worth US$ 5699 million in 2022 and is forecast to a readjusted size of US$ 7844 million by 2028 with a CAGR of 9% during the forecast period 2022-2028. The drug is used to treat certain types of cancer(for example,acute lymphoblastic leukemia,chronic myeloid leukemia, gastrointestinal stromal […]
